Organisation
Basic (bio-) Medical Sciences
Department
Basic and applied biomedical research, and biomedical science-based higher education.
Current researchers
1 - 10 of 155 results
- Geoffrey Aerts (Member)
- Diana Al Delbany (Member)
- Leen Ali (Member)
- Dorien Autaers (Member)
- Yoni Baert (Member)
- M.H.C. Bakkus (Member)
- Jonathan Baldan (Member)
- Jonathan Bastos (Member)
- Thomas Benoot (Member)
- Giada Bertazzon (Member)
Projects
1 - 10 of 132
- HERCULES: Development of an innovative muscle-directed gene therapy platform for lysosomal storage disordersFrom1 Jan 2023 → TodayFunding: FWO research project (including WEAVE projects)
- Liver and brain organoids to model human pluripotent stem cell tumorigenesisFrom1 Jan 2023 → TodayFunding: FWO research project (including WEAVE projects)
- ELIXIR Infrastructure for Data and Services to strengthen Life-Sciences Research in Flanders.From1 Jan 2023 → TodayFunding: FWO International research infrastructure (IRI)
- The Genetic Component to Infertility and Early Developmental FailureFrom1 Jan 2023 → TodayFunding: BOF - Methusalem
- Erasmus Standard Budget-based + LS Type II : European Universities Transforming to an Open Inclusive Academy - Making Organisational and Real Evolution (EUTOPIA – MORE)From1 Dec 2022 → TodayFunding: EU - out of framework - indefinite
- sustAIn.brussels : Creating a lever for a future-proof and sustainable economy for Brussels enabled by AI and other emerging digital technologies.From1 Nov 2022 → TodayFunding: Other EU initiatives out of framework
- Identifying causes of emergence of chromosomal abnormalities in human cleavage stage embryos.From1 Nov 2022 → TodayFunding: FWO fellowships
- EDIH 2022: Creating a lever for a future-proof and sustainable economy for Brussels enabled by AI and other emerging digital technologiesFrom1 Nov 2022 → TodayFunding: Brussels Capital Region
- The role of the epiplayer RBBP4 in malignant progression and relapse in multiple myeloma.From1 Nov 2022 → TodayFunding: FWO fellowships
- Spatial positioning in pancreatic tumors: mapping and deconstructing the underlying SLIT-ROBO pathwayFrom1 Nov 2022 → 22 Jan 2024Funding: FWO fellowships
Publications
1 - 10 of 1109
- PRC2 targeting is a therapeutic strategy for EZ score defined high-risk multiple myeloma patients and overcome resistance to IMiDs
Authors: Laurie Herviou, Alboukadel Kassambara, Stéphanie Boireau, Nicolas Robert, Guilhem Requirand, Carsten Müller-Tidow, Laure Vincent, Anja Seckinger, Hartmut Goldschmidt, Guillaume Cartron, et al.
- DNA methylation score is predictive of myeloma cell sensitivity to 5-azacitidine
Authors: Jerome Moreaux, Angelique Bruyer, Jean-Luc Veyrune, Hartmut Goldschmidt, Dirk Hose, Bernard Klein
Pages: 613-616 - Cellular uptake kinetics of bortezomib in relation to efficacy in myeloma cells and the influence of drug transporters
Authors: Jannick Clemens, Anja Seckinger, Dirk Hose, Dirk Theile, Magdalena Longo, Walter Emil Haefeli, Jürgen Burhenne, Johanna Weiss
Pages: 281-291 - Forced KLF4 expression increases the generation of mature plasma cells and uncovers a network linked with plasma cell stage
Authors: Matthieu Schoenhals, Michel Jourdan, Anja Seckinger, Véronique Pantesco, Dirk Hose, Alboukadel Kassambara, Jérôme Moreaux, Bernard Klein
Pages: 1919-1928 - Response-adapted lenalidomide maintenance in newly diagnosed myeloma
Authors: Hartmut Goldschmidt, Elias K Mai, Jan Dürig, Christof Scheid, Katja C Weisel, Christina Kunz, Uta Bertsch, Thomas Hielscher, Maximilian Merz, Markus Munder, et al.
Pages: 1853-1865 - CAMK1D Triggers Immune Resistance of Human Tumor Cells Refractory to Anti-PD-L1 Treatment
Authors: Valentina Volpin, Tillmann Michels, Antonio Sorrentino, Ayse N Menevse, Gertrud Knoll, Madlen Ditz, Vladimir M Milenkovic, Chih-Yeh Chen, Anchana Rathinasamy, Klaus Griewank, et al.
Pages: 1163-1179 - (18)F-FDG dynamic PET/CT in patients with multiple myeloma
Authors: Christos Sachpekidis, Elias K Mai, Hartmut Goldschmidt, Jens Hillengass, Dirk Hose, Leyun Pan, Uwe Haberkorn, Antonia Dimitrakopoulou-Strauss
Pages: e300-e307 - Bortezomib-based induction therapy with high or low-dose dexamethasone in newly diagnosed, transplant-eligible multiple myeloma
Authors: Elias K Mai, Thomas Hielscher, Uta Bertsch, Jana Schlenzka, Hans J Salwender, Markus Munder, Christian Gerecke, Ulrich Dührsen, Peter Brossart, Kai Neben, et al.
Pages: 258-261 - Krüppel-like factor 4 blocks tumor cell proliferation and promotes drug resistance in multiple myeloma
Authors: Matthieu Schoenhals, Alboukadel Kassambara, Jean-Luc Veyrune, Jerome Moreaux, Hartmut Goldschmidt, Dirk Hose, Bernard Klein
Pages: 1442-1449 - THE BILE ACID TAUROURSODEOXYCHOLIC ACID COOPERATES WITH N-ACETYLCYSTEINE IN THE TREATMENT OF EXPERIMENTAL ACETAMINOPHEN-INDUCED HEPATOTOXICITY
Authors: A. Paridaens, L. Devisscher, S. Raevens, E. Bogaerts, Yves-Paul Vandewynckel, X. Verhelst, Inge Mannaerts, , Isabelle Colle, A. Geerts
Pages: S227-S228